The health minister says the treatment could give those with the condition a chance to 'live their life to the fullest'.
A migraine pill which could change the lives of thousands of people who suffer from the 'incredibly debilitating' condition should be made accessible on the NHS 'swiftly', a charity has said. Atogepant - sold under the brand name Aquipta and made by AbbVie - has been given the green light for NHS use under new final draft guidance from the National Institute for Health and Care Excellence .
Read more on Sky News: Xylazine: Powerful 'zombie drug' known as Tranq has 'penetrated' UK market, experts warnBridget Jones is back: Zellweger will star in fourth film - but a key love interest won't return 'We now need to ensure access is swift, so that migraine patients can benefit from them as quickly as possible.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
'Very profitable' 170-year-old hotel in Scottish Highlands on saleA 170-YEAR-OLD hotel in the Highlands has been put on the market ...
Baca lebih lajut »
'Chaos' on Tredworth's High Street as first mural of huge new project unveiledIt's the first of 170 buildings to be given a much-need facelift.
Baca lebih lajut »
East Mids Rail announces £60 million upgrades including new seatsClass 170 trains running across Nottinghamshire are among those being upgraded
Baca lebih lajut »
Dunelm chair that 'looks expensive' reduced in 50% off saleDunelm shoppers have left more than 170 five star reviews labelling the chair 'gorgeous' and 'comfortable'
Baca lebih lajut »
Young adults with migraine, other nontraditional risk factors may have higher stroke riskAdults younger than 35 to 45 years old may have a higher risk of developing a stroke from nontraditional risk factors such as migraines than from traditional risks like high blood pressure. That's according to new research published today in Circulation: Cardiovascular Quality and Outcomes.
Baca lebih lajut »
Fury as NHS guidance states children as young as 15 CAN be given irreversible 'gender-affirming'...Campaigners last night said the policy was 'extremely worrying'. Helen Joyce, of women's rights group Sex Matters, called on the NHS to rethink the policy based on 'ideology' not 'clinical beneftis'.
Baca lebih lajut »